CoChat

Long‐term complications in survivors of advanced stage neuroblastoma

Laverdière, Caroline, Cheung, Nai‐Kong V., Kushner, Brian H., Kramer, Kim, Modak, Shakeel, LaQuaglia, Michael P., Wolden, Suzanne, Ness, Kirsten K., Gurney, James G., Sklar, Charles A. · 2005 · Pediatric Blood & Cancer
Cited by 169

The DOI matches its Crossref record.

Abstract

Background: Few studies have assessed late effects in neuroblastoma (NB) survivors, particularly those with advanced stage disease. Methods: Retrospective analysis of a cohort of advanced stage NB survivors followed in a late effect clinic at a single institution. Screening tests to detect late effects were tailored depending on the individual's treatment exposures. Results: The study included 63 survivors (31 males). The median age at diagnosis was 3.0 years. The median follow‐up from diagnosis was 7.06 years. All patients had surgery and received chemotherapy, 89% received radiation therapy (RT), 62% immunotherapy, and 56% autologous stem cell transplant. Late complications were detected in 95% of survivors and included: hearing loss (62%), primary hypothyroidism (24%), ovarian failure (41% of females), musculoskeletal (19%), and pulmonary (19%) abnormalities. The majority of complications were moderate, with only 4% being life‐threatening. Survivors who received cisplatin were at greater risk to develop hearing loss compared to those not so treated (OR 9.74; 95% CI: 0.9–101.6). A total dose of cyclophosphamide greater than 7.4 g was associated with ovarian failure (P = 0.02). Conclusions: Late complications occur frequently in survivors of advanced stage NB. The majority of these problems are of mild‐moderate severity. Long‐term follow‐up (LFTU) and screening of this population is essential. © 2005 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pbc.20331

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 169

Metadata

Authors
Laverdière, C., Cheung, N. V., Kushner, B. H., Kramer, K., Modak, S., LaQuaglia, M. P., Wolden, S., Ness, K. K., Gurney, J. G., & Sklar, C. A.
Venue
Pediatric Blood & Cancer
Publisher
Wiley
Published
2005-02-15
Volume
45
Issue
3
Pages
324-332
ISSN
  • 1545-5009 (ISSN-L)
  • 1545-5017
OpenAlex
W2106739013
Cited by
169
References
0
FWCI
5.82
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long‐term complications in survivors of advanced stage neuroblastoma. https://app.cochat.ai/papers/10.1002/pbc.20331
The paper
Laverdière, C., Cheung, N. V., Kushner, B. H., Kramer, K., Modak, S., LaQuaglia, M. P., Wolden, S., Ness, K. K., Gurney, J. G., & Sklar, C. A. (2005). Long‐term complications in survivors of advanced stage neuroblastoma. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.20331

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.